Advertisement
Singapore markets open in 1 hour 47 minutes
  • Straits Times Index

    3,138.93
    -18.39 (-0.58%)
     
  • S&P 500

    5,069.76
    -8.42 (-0.17%)
     
  • Dow

    38,949.02
    -23.39 (-0.06%)
     
  • Nasdaq

    15,947.74
    -87.56 (-0.55%)
     
  • Bitcoin USD

    61,817.01
    +4,928.61 (+8.66%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,624.98
    -58.04 (-0.76%)
     
  • Gold

    2,043.60
    +0.90 (+0.04%)
     
  • Crude Oil

    78.21
    -0.33 (-0.42%)
     
  • 10-Yr Bond

    4.2740
    -0.0410 (-0.95%)
     
  • Nikkei

    39,208.03
    -31.49 (-0.08%)
     
  • Hang Seng

    16,536.85
    -253.95 (-1.51%)
     
  • FTSE Bursa Malaysia

    1,545.59
    -13.21 (-0.85%)
     
  • Jakarta Composite Index

    7,328.64
    -7,285.32 (-49.85%)
     
  • PSE Index

    6,876.52
    +15.85 (+0.23%)
     

Why Iovance Biotherapeutics Stock Is Marching Higher Today

Why Iovance Biotherapeutics Stock Is Marching Higher Today

On a brutal day for biotech stocks, Iovance Biotherapeutics (NASDAQ: IOVA) is defying the broader trend across the space. Meanwhile, the iShares Biotechnology ETF was down by 1.6%, and the SPDR S&P Biotech ETF was in the red by 2.63% at the same point in today's trading session. While its financial results are largely immaterial at this point in its lifecycle, the company did note that it is making progress toward the possible commercial debut of lifileucel, a polyclonal tumor-infiltrating lymphocyte (TIL) therapy indicated for patients with advanced melanoma.